Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TXNRD1 | Q16881 | 18/20 | 0.56 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | GFER | P55789 | 1/20 | 0.52 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.52 |
| ▸ | JAK2 | O60674 | 1/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | GSR | P00390 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31056308 | 1.00 | TXNRD1 (0.56) | TXNRD1S1PR4MAPTS1PR1MAPK1 | |
| SCHEMBL6027123 | 0.94 | TXNRD1 (0.51) | TXNRD1S1PR4MAPTS1PR1MAPK1 | |
| SCHEMBL13657691 | 0.88 | TXNRD1 (0.46) | TXNRD1S1PR4MAPTS1PR1MAPK1 | |
| SCHEMBL2411887 | 0.82 | TDP1 (0.39) | TXNRD1S1PR4MAPTS1PR1MAPK1 | |
| SCHEMBL2302904 | 0.81 | MAPT (0.53) | TXNRD1MAPTMAPK1RAB9AGSR | |
| SCHEMBL1428159 | 0.80 | TXNRD1 (0.58) | TXNRD1S1PR4MAPTS1PR1MAPK1 | |
| SCHEMBL29830024 | 0.80 | TXNRD1 (0.58) | TXNRD1S1PR4MAPTS1PR1MAPK1 | |
| SCHEMBL1848090 | 0.80 | TXNRD1 (0.58) | TXNRD1S1PR4MAPTS1PR1MAPK1 | |
| SCHEMBL10740434 | 0.80 | TXNRD1 (0.58) | TXNRD1S1PR4MAPTS1PR1MAPK1 | |
| SCHEMBL27175931 | 0.80 | TXNRD1 (0.62) | TXNRD1S1PR4MAPTS1PR1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118994151-A | Imidazopyridone compounds binding to sigma-2 receptor, preparation method and application thereof | 北京师范大学 | 2024-11-22 | — | — | CN | claimed |
| CN-102040607-A | Synthetic process of intermediate for producing tenatoprazole | TIANJIN SANNONGJIN TECHNOLOGY | 2011-05-04 | — | — | CN | claimed |
| CN-1982311-B | Synthesis of 2-hydrophobic-5-methoxy-diazole [4,5-b]-dipyridine | WEIZHI FINE CHEMICAL CO LTD TIANJIN | 2010-10-13 | — | — | CN | claimed |
| US-7256295-B2 | Process for producing 2,3-diamino-6-methoxypyridine | JUBILANT ORGANOSYS LIMITED (IN) | 2007-08-14 | — | — | US | claimed |
| CN-1982311-A | Synthesis of 2-hydrophobic-5-methoxy-diazole [4,5-b]-dipyridine | WEIZHI PREC CHEMICAL CO LTD TI (CN) | 2007-06-20 | — | — | CN | claimed |
| US-20060080790-A1 | Process for producing 2,3-diamino-6-methoxypyridine | JUBILANT ORGANOSYS LIMITED (IN) | 2006-04-20 | — | — | US | claimed |
| EP-0199951-B1 | PROCESS FOR THE PREPARATION OF 2-AMINO-3-NITRO-6-(4-FLUOROBENZYLAMINO) PYRIDINE AND OF 2-AMINO-3-CARBETHOXYAMINO-6-(4-FLUOROBENZYLAMINO) PYRIDINE | ASTA Pharma Aktiengesellschaft (DE) | 1991-01-23 | — | — | EP | claimed |
| US-4785110-A | Process for the production of 2-amino-3-nitro-6-(4-fluorobenzylamino)-pyridine | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1988-11-15 | — | — | US | claimed |
| EP-0199951-A2 | Process for the preparation of 2-amino-3-nitro-6-(4-fluorobenzylamino) pyridine and of 2-amino-3-carbethoxyamino-6-(4-fluorobenzylamino) pyridine | ASTA Pharma Aktiengesellschaft (DE) | 1986-11-05 | — | — | EP | claimed |
| WO-2026088070-A1 | COMPOUNDS | PFIZER INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-4121423-B1 | TETRAZOLE DERIVATIVES | MERCK PATENT GMBH (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4725493-A2 | POLYCYCLIC COMPOUNDS FOR INHIBITING RNA HELICASE DHX33 AND USE THEREOF | Shenzhen Keye Life Technologies, Co., Ltd. (CN) | 2026-04-15 | — | — | EP | disclosed |
| EP-4121429-B1 | CONDENSED PYRIDINE DERIVATIVES SUBSTITUED BY AMIDE FUNCTIONS AS ACSS2 INHIBITORS | MERCK PATENT GMBH (DE) | 2025-08-13 | — | — | EP | disclosed |
| CN-115335371-B | Tetrazole derivatives | 默克专利股份公司 | 2024-12-27 | — | — | CN | disclosed |
| EP-0623620-A1 | 5-HT3 Pyrrolopyrazine derivatives | ADIR ET COMPAGNIE (FR) | 1994-11-09 | — | — | EP | disclosed |
| EP-0199951-B1 | PROCESS FOR THE PREPARATION OF 2-AMINO-3-NITRO-6-(4-FLUOROBENZYLAMINO) PYRIDINE AND OF 2-AMINO-3-CARBETHOXYAMINO-6-(4-FLUOROBENZYLAMINO) PYRIDINE | ASTA Pharma Aktiengesellschaft (DE) | 1991-01-23 | — | — | EP | disclosed |
| US-4785110-A | Process for the production of 2-amino-3-nitro-6-(4-fluorobenzylamino)-pyridine | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1988-11-15 | — | — | US | disclosed |
| US-4785110-A | Process for the production of 2-amino-3-nitro-6-(4-fluorobenzylamino)-pyridine | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1988-11-15 | — | — | US | disclosed |
| EP-0199951-A2 | Process for the preparation of 2-amino-3-nitro-6-(4-fluorobenzylamino) pyridine and of 2-amino-3-carbethoxyamino-6-(4-fluorobenzylamino) pyridine | ASTA Pharma Aktiengesellschaft (DE) | 1986-11-05 | — | — | EP | disclosed |
| EP-0199951-A2 | Process for the preparation of 2-amino-3-nitro-6-(4-fluorobenzylamino) pyridine and of 2-amino-3-carbethoxyamino-6-(4-fluorobenzylamino) pyridine | ASTA Pharma Aktiengesellschaft (DE) | 1986-11-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060080790-A1 | Process for producing 2,3-diamino-6-methoxypyridine | TET2, QDPR, PNMT | TXNRD1 2840/4885S1PR4 880/4885MAPT 1845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.